HFS
NVO

Hopwood Financial Services’s Novo Nordisk NVO Stock Holding History

Hopwood Financial Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-78
Closed -$4.33K – 225
2025
Q3 		$4.33K Hold
78
– – ﹤0.01% 284
2025
Q2 		$5.38K Hold
78
– – ﹤0.01% 252
2025
Q1 		$5.42K Hold
78
– – ﹤0.01% 258
2024
Q4 		$6.71K Buy
+78
New +$8.44K 0.01% 260

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hopwood Financial Services's NVO Position: Q4 2025 in Review

Hopwood Financial Services sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 78 shares — an estimated $4.33K sold.

Hopwood Financial Services first reported a position in NVO in Q4 2024 and held it in 4 quarters. The position peaked at $6.71K in Q4 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Hopwood Financial Services reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Hopwood Financial Services sold 78 Novo Nordisk shares in Q4 2025, an estimated $4.33K.
  • Hopwood Financial Services first reported a position in Novo Nordisk in Q4 2024 and held it in 4 quarters.
  • Hopwood Financial Services's Novo Nordisk position peaked at $6.71K in Q4 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Hopwood Financial Services's 13F filing for Q4 2025, filed 16 Jan 2026.